Zosano Pharma Corporation (ZSAN)

4.2 +0.02 (+0.478%)

IEX Real-Time Price

April 25, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 4.18

Price Open 4.15

Volume: 299,431

Avg Volume: 1M

Market Cap: 56.59M

P/E Ratio -0.23

52 Wk Range 3.6101-35.4



ZSAN Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-03-29
11.98M
488,123
0.17
4.07%

2018-01-12
37.97M
4.01M
5.74
10.57%

2017-12-29
37.97M
4.15M
5.48
10.93%

2017-12-15
38.17M
4.2M
6.53
11.01%




ZSAN Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-08
Q1 2018
N/A
-5.40 (1)
0.00
0.00

2018-03-12
Q4 2017
N/A
-4.80 (1)
-3.80
1.00

2018-03-07
Q4 2017
N/A
-0.24 (1)
0.00
0.00

2017-11-09
Q3 2017
AMC
-0.15 (1)
-0.20
-0.05

News

Zosano Pharma's (ZSAN) Operational Update Conference Call (Transcript) (2018-04-04 17:28 SeekingAlpha)

Zosano Pharma Corporation (ZSAN) Operational Update Conference Call April 04, 2018 04:30 PM ET Executives Georgia Erbez - Chief Business Officer and Chief Financial Officer John Walker - Chairman and Chief Executive Officer Don Kellerman - Vice President of Clinical Development a…

 

Zosano Pharma to host investor call April 4 (2018-04-02 13:07 SeekingAlpha)

Volatile nano cap Zosano Pharma ( ZSAN +0.6% ) will host a conference call on Wednesday, April 4, at 4:30 pm ET to update investors on its business. More news on: Zosano Pharma, Healthcare stocks news, Stocks on the move, Read more …

 

Midday Gainers / Losers (3/29/2018) (2018-03-29 13:10 SeekingAlpha)

Gainers: GALT +22% . OTCQB:MBVX +18% . CDMO +17% . UNT +17% . JNP +16% . MOV +16% . REED +16% . SPB +15% . HRG +16% . PSDV +15% . More news on: Galectin Therapeutics, Inc., MabVax Therapeutics Holdings, Inc., Avid Bioservices, Inc., Stocks on the move, , R…

 

Zosano prices stock offering at $5; shares down 44% (2018-03-29 09:43 SeekingAlpha)

Nano cap Zosano Pharma ( ZSAN -43.5% ) prices its public offering of 10M shares of common stock at $5 per share. Underwriters over-allotment is an additional 1.5M shares. Closing date is April 3. More news on: Zosano Pharma, Healthcare stocks news, Stocks on the move, Read more …...

 

Premarket Losers as of 9:05 am (3/29/2018) (2018-03-29 09:11 SeekingAlpha)

ZSAN -45% after declaring its prospectus for a 10M-sharestock offeringeffective. More news on: Zosano Pharma, GameStop Corp., Euro Tech Holdings Company Limited, Stocks on the move, , Read more …

 


Statistics

Shares Outstanding: 13.47M

Top 15 Institution Percent: 5.20

Price To Sales: N/A

Price To Book: 7.91

Revenue: N/A

Gross Profit: N/A

Cash: 85.42M

Debt: 28.97M

Return On Assets: -139.10

Return On Equity: -478.53

Profit Margin: N/A

Price History

Beta: 1.92

50-day Moving Avg: 8.50

200-day Moving Avg: 13.95

YTD Change: -60.38

5-day Change: -1.64

1-month Change: -71.13

3-month Change: -42.51

6-month Change: -71.47

1-year Change: -87.35

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Zosano Pharma Corporation

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.zosanopharma.com

Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications.